BETAPLUS PHARMA
- 0479.037.369
- BE0479037369
- Avenue Hippocrate 10, 1200 Woluwe-Saint-Lambert
- See the 37 companies at this address
- 16 December 2002
Profile
Official information from the CBE (FPS Economy).
BETAPLUS PHARMA is a Belgian company (Société anonyme) whose registered office is established at 1200 Woluwe-Saint-Lambert. Its main activity falls under “Fabrication d'autres produits pharmaceutiques” (NACE 21209).
- Legal form
- Société anonyme
- Legal situation
- Situation normale
- Date of incorporation
- 16 December 2002
- Main activity (NACE)
- 21209Fabrication d'autres produits pharmaceutiques
An activity that is, on the face of it, not covered by anti-money-laundering law. Learn more
Company names
Official names in several languages: legal name, trade name, abbreviation.
- betaplus
Secondary activities
4 additional NACE codes declared.
Your risk analysis on this company
AML Company ran BETAPLUS PHARMA through your due diligence questionnaire. Here are the first findings.
What is the geographic exposure of the client and of its transactions?
Belgium only· Registered office published in the register
What is the company's solvency and lifecycle status?
Trading, no proceedings· Legal situation published in the register
Sanctions screening, politically exposed persons, ultimate beneficial owners, source of funds: AML Company runs them, documents them and keeps the proof in your file.
Run the full analysisThis preview is not a due diligence measure: it pre-qualifies questions from public data. Identifying the client and its ultimate beneficial owners requires documents collected and verified.
Establishments
1 active establishment unit declared with the CBE.
Finances & financial health
Annual accounts filed with the Central Balance Sheet Office (CBSO, National Bank of Belgium) and an aggregate health score (Altman Z″ model, completed with qualitative factors).
Equity & result
| Financial year | Equity | Result | Turnover / gross margin | Headcount (FTE) |
|---|---|---|---|---|
| 2025 | €22,327,343 | €1,271,395 | €5,412,070turnover | 11,3 |
| 2024 | €21,055,948 | €1,643,069 | €5,396,027turnover | 11,5 |
| 2023 | – | – | - | – |
| 2022 | €18,443,607 | €1,230,921 | €5,131,585turnover | 11,5 |
Financial ratios
Solvency, liquidity and profitability, computed year by year from the filed annual accounts.
Equity / balance sheet total
Current assets / debts due within one year
Result for the year / turnover
Operating result / turnover
This year's filing does not carry the item the calculation needs.
Debts due after one year / balance sheet total
Result for the year / equity
Balance sheet structure
| Ratio | 2025 | 2024 | 2023 | Trend |
|---|---|---|---|---|
| Solvency | 89,8% 0,8% | 89% | - | |
| Liquidity | 24,55 x 2,47 | 22,08 x | - | |
| Net margin | 23,5% 7% | 30,4% | - | |
| Operating margin | 23,2% 2,4% | 25,6% | - | |
| Long-term debt | - | - | - | - |
| Return on equity | 5,7% 2,1% | 7,8% | - |
Ratios computed by AML Company from the items filed in the balance sheet and the income statement. They are not filed figures as such: the underlying amounts appear in the key figures above.
Filing history (26)▾
| Financial year | Filing | Filing type | Model | Source |
|---|---|---|---|---|
| 01/01/2025 → 31/12/2025 | 03/08/2026 | Initial | m01-f | BNB |
| 01/01/2024 → 31/12/2024 | 16/07/2025 | Initial | m01-f | BNB |
| 01/01/2023 → 31/12/2023 | 02/07/2024 | Initial | m01-f | BNB |
| 01/01/2022 → 31/12/2022 | 10/10/2023 | Correction | m01-f | BNB |
| 01/01/2022 → 31/12/2022 | 21/08/2023 | Initial | m01-f | BNB |
| 26/12/2020 → 31/12/2021 | 15/11/2022 | Initial | m01-f | BNB |
| 01/01/2020 → 25/12/2020 | 10/06/2021 | Initial | m01-f | BNB |
| 01/01/2019 → 31/12/2019 | 04/08/2020 | Initial | m01-f | BNB |
| 01/01/2018 → 31/12/2018 | 06/08/2019 | Initial | m02-f | BNB |
| 01/01/2017 → 31/12/2017 | 23/08/2018 | Initial | m02-f | BNB |
| 01/01/2016 → 31/12/2016 | 05/10/2017 | Correction | m02-f | BNB |
| 01/01/2016 → 31/12/2016 | 24/08/2017 | Initial | m02-f | BNB |
Source: CBSO (NBB) filings, Belgian chart-of-accounts headings 9904 (result), 10/15 (equity), 9900 (gross margin), 9087 (workforce in FTE). Data available for filings from 2022 onwards.
The grade, the score out of 100, the Altman Z″ zone and the list of public alerts are for members only.
Notices in the Belgian Official Gazette
Official acts and notices: incorporation, changes to the articles, appointments, dissolutions.
- DEMISSIONS, NOMINATIONS9 April 2026
- DEMISSIONS, NOMINATIONS22 September 2025
- DEMISSIONS, NOMINATIONS3 September 2024
- DEMISSIONS, NOMINATIONS27 September 2023
- DEMISSIONS, NOMINATIONS23 February 2023
Source: Belgian Official Gazette (FPS Justice). The links open the official PDFs.
What the BETAPLUS PHARMA record does not say
Two readings of the register the raw data does not give: anti-money-laundering scope, and whether the filing deadline was met.
Is BETAPLUS PHARMA subject to anti-money-laundering obligations in Belgium?
Did BETAPLUS PHARMA file its annual accounts on time?
Company timeline
Every dated event in the company's life, from filed accounts to notices published in the Belgian Official Gazette, in a single thread.
10 AI-analysed dimensions are not shown.
- 2026
- 3 August 2026Annual accounts filed·Financial year ended 31 December 2025 · Model m01-fFiled accounts2026-00373364
- 2025
- 16 July 2025Annual accounts filed·Financial year ended 31 December 2024 · Model m01-fFiled accounts2025-00288402
- 2024
- 2 July 2024Annual accounts filed·Financial year ended 31 December 2023 · Model m01-fFiled accounts2024-00222313
- 2023
- 10 October 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m01-fFiled accounts2023-00485502
- 21 August 2023Annual accounts filed·Financial year ended 31 December 2022 · Model m01-fFiled accounts2023-00380305
- 2022
- 15 November 2022Annual accounts filed·Financial year ended 31 December 2021 · Model m01-fFiled accounts2022-20519894
Registry record since 7 September 2026
The KBO publishes its changes as a monthly delta and never restates the past: our record starts on that date, not at the company's incorporation. No change recorded since that date. A missing row says nothing about the company, only about how far back our record goes.
AI extraction of strategic AML data
The official notices in the Belgian Official Gazette are analysed by our AI engine to extract automatically the information that matters for your due diligence and your AML duties.
- Legal life
- Restructuring
- Capital
- Legal form
- Incorporation
- Directors
- Beneficial owners
- Registered office
- Company name
- Notarial deeds
Similar companies
Same business sector and geographic area.
MERIDIAN BIOSCIENCE EUROPE
NO HEADACHE
SOCIÉTÉ D’ÉTUDES, COMMERCIALISATION ET RÉALISATION
BIO MINERALS
UNISENSOR
THYMOLUX
BAXALTA BELGIUM MANUFACTURING
DIAGAM
TELIX INNOVATIONS
Step it up
Full analysis unlocked.
Create an account to unlock the detailed analysis: health score, full history, alerts and PDF exports.